Study of DISC-0974-201 in Participants With IBD and Anemia

Study Summary

This is a Phase 2, multicenter, randomized, double-blind placebo-controlled study of DISC-0974 to evaluate safety, tolerability, and efficacy in participants with IBD and anemia of inflammation.

Conditions

Inflammatory Bowel Disease (IBD)Anemia Inflammatory Bowel Disease (IBD); Anemia

Interventions / Drugs

DISC-0974 Placebo

View on ClinicalTrials.gov ↗

Sponsor

Study Details

Enrollment21 participants

Primary Completion—

Lead SponsorDisc Medicine, Inc

Data Retrieved2026-04-11 04:18:08.225384+00:00

Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.